UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
| Date of Report (Date of earliest event reported) | August 22, 2013 |
| ProUroCare Medical Inc. | ||
| (Exact name of registrant as specified in its charter) | ||
| Nevada | 000-51774 | 20-1212923 |
| (State or other jurisdiction | (Commission | (IRS Employer |
| of incorporation) | File Number) | Identification No.) |
| 6440 Flying Cloud Dr., Suite 101, Eden Prairie, MN | 55344 | |
| (Address of principal executive offices) | (Zip Code) | |
| Registrant’s telephone number, including area code | 952-476-9093 | |
| N/A | ||
| (Former name or former address, if changed since last report.) | ||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.07 Submission of Matters to a Vote of Security Holders
ProUroCare Medical Inc. (the “Company”)held its Annual Meeting of Shareholders on August 22, 2013, at which the shareholders took the following actions:
Matter 1: Election of Directors
The director nominees described in the Company's Proxy Statement were elected as follows:
| For | Withhold | Abstain | Broker Non-Votes | |||||||||||||
| Stanton D. Myrum | 7,474,456 | 30,000 | 6,560 | 9,275,582 | ||||||||||||
| James L. Davis | 7,472,936 | 31,520 | 6,560 | 9,275,582 | ||||||||||||
| Robert J. Rudelius | 7,474,456 | 30,000 | 6,560 | 9,275,582 | ||||||||||||
| Scott E. Smith | 7,474,456 | 30,000 | 6,560 | 9,275,582 | ||||||||||||
Each director has consented to hold office until the next annual meeting of shareholders or until his successor is elected and shall have qualified.
Matter 2: Appointment of Independent Registered Public Accounting Firm
The appointment of Baker Tilly Virchow Krause, LLP as the Company’s independent registered public accounting firm for the 2013 fiscal year was ratified as follows:
| For | Against | Abstain | ||||||||
| 16,732,538 | 48,060 | 6,000 | ||||||||
Item 7.01 Regulations FD Disclosure
On August 22, 2013 the CEO of ProUroCare made a Presentation at the annual meeting of shareholders that the Company intends to post on its website. The Presentation is attached herein as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
| 99.1 | Presentation at the August 22, 2013 annual meeting of shareholders. |
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| PROUROCARE MEDICAL INC. | ||
| August 26, 2013 | By: | /s/Alan Shuler |
| Alan G. Shuler Chief Financial Officer and Secretary | ||